TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 80 filers reported holding TERNS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,515,000 | -52.1% | 500,000 | -16.6% | 0.76% | -53.0% |
| Q2 2023 | $5,247,095 | -33.6% | 599,668 | -10.2% | 1.62% | -50.3% |
| Q1 2023 | $7,908,196 | +11.0% | 667,922 | -4.6% | 3.26% | +60.1% |
| Q4 2022 | $7,126,000 | +8283.5% | 700,000 | +4736.6% | 2.04% | +6931.0% |
| Q3 2022 | $85,000 | – | 14,473 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 6,657,992 | $33,489,700 | 3.67% |
| ACUTA CAPITAL PARTNERS, LLC | 555,260 | $2,792,958 | 1.87% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6,041,910 | $30,390,807 | 1.64% |
| VR Adviser, LLC | 3,092,273 | $15,554,133 | 1.64% |
| Fairmount Funds Management LLC | 2,040,000 | $10,261,200 | 1.24% |
| Decheng Capital Management III (Cayman), LLC | 714,285 | $3,592,854 | 1.20% |
| Deep Track Capital, LP | 6,000,000 | $30,180,000 | 1.16% |
| Orbimed Advisors | 7,619,135 | $38,324,249 | 0.81% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 500,000 | $2,515,000 | 0.76% |
| GREAT POINT PARTNERS LLC | 645,899 | $3,248,872 | 0.59% |